key: cord-0827814-mku5wkki
authors: Le Cleach, L.; Fourati, S.; Sbidian, E.; Beylot‐Barry, M.
title: Negative tests for SARS‐CoV‐2 infection do not rule out its responsibility for chilblains: reply from authors
date: 2020-08-13
journal: Br J Dermatol
DOI: 10.1111/bjd.19486
sha: 5a89a8ddae83825c1e81e22053b804b787b06f7f
doc_id: 827814
cord_uid: mku5wkki

With great interest, we read Battesti and Descamps comment on our recently published study in this journal. Their comment is based on their findings that histological and immunostaining of skin biopsy of 7 cases of “epidemic chilblains” with negative SARS‐CoV‐2 RT‐PCR and repeated serology was similar to those of a historical series of 11 cases of chilblains lupus notably for high expression of CD123 and MxA a type‐I interferon (IFN‐I)‐induced protein in both groups(1).

With great interest, we read Battesti and Descamps comment on our recently published study in this journal. Their comment is based on their findings that histological and immunostaining of skin biopsy of 7 cases of "epidemic chilblains" with negative SARS-CoV-2 RT-PCR and repeated serology was similar to those of a historical series of 11 cases of chilblains lupus notably for high expression of CD123 and MxA a type-I interferon (IFN-I)-induced protein in both groups 1 . Thus, they hypothesized that chilblains observed during Covid-19 outbreak are linked to a high IFN response to SARS-CoV-2 leading to both negative RT-PCR and serology due to this effective antiviral response and that chilblains development is due to IFN production. Their hypothesis is notably based on recent publication showing that impaired IFN response is observed in critically ills COVID-19 patients. 2, 3 Even we agree that it cannot be absolutely excluded; there is no evidence that their reported cases without RT-PCR or serological confirmation are really related to the infection. In our series, where most cases were negative for SARS-CoV-2 both by PCR and serology, it is highly unlikely that they are false negatives as serology was performed an average of 3 weeks after the onset of manifestations Secondly, their hypothesis warranted further explorations notably to confirm the high IFN production in patients with chilblains and negative serology and PCR. Dosage of IFN was performed in blood samples in two patients in our series and showed a low level of IFN production. In addition, to extrapolate that high IFN production would lead to negative PCR and serology starting from the findings that profoundly impaired IFN-I response characterized by low interferon production is observed in critically ills patients is a very speculative hypothesis. Indeed, such high interferon response could be expected to cause other clinical manifestations in addition to chilblains.

Finally, it was previously showed that CD123 immunostaining is not different between chilblain lupus erythematosus and idiopathic chilblains 4 . So, the fact to observe this expression in "epidemic chilblain" is not an argument for attributing them to SARS-Cov2. We also observed in 5 cases a high expression of CD123 in patients with negative serology and without any associated infectious signs.

New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Type I IFN immunoprofiling in COVID-19 patients

Comparative Analysis of Chilblain Lupus Erythematosus and Idiopathic Perniosis: Histopathologic Features and Immunohistochemistry for CD123 and CD30

Accepted Article